The Baddi manufacturing unit of Glenmark Pharmaceuticals Ltd (BSE Scrip Code: 532296, NSE Symbol: GLENMARK) was inspected by the leading European regulator, SUKL (State Institute for Drug control), Czech Republic in the week of Oct 21, 2019. The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfill GMP recommendations of WHO.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.339.7 as compared to the previous close of Rs. 341.35. The total number of shares traded during the day was 72257 in over 1497 trades.
The stock hit an intraday high of Rs. 345.6 and intraday low of 335.45. The net turnover during the day was Rs. 24531441.